Skip to main content
Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.600
-0.012 (-1.96%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Cytosorbents Revenue

In the year 2025, Cytosorbents had annual revenue of $37.06M with 4.12% growth. Cytosorbents had revenue of $9.23M in the quarter ending December 31, 2025, with 0.91% growth.

Revenue (ttm)
$37.06M
Revenue Growth
+4.12%
P/S Ratio
1.02
Revenue / Employee
$287,310
Employees
129
Market Cap
37.62M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202537.06M1.47M4.12%
Dec 31, 202435.60M4.51M14.51%
Dec 31, 202331.08M-3.60M-10.39%
Dec 31, 202234.69M-8.48M-19.64%
Dec 31, 202143.17M2.16M5.27%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accuray 436.97M
Nortech Systems 118.37M
Pulmonx 90.50M
TELA Bio 80.28M
Myomo 40.93M
electroCore 32.03M
Elutia 12.29M
NeuroOne Medical Technologies 11.72M
Revenue Rankings

CTSO News

More News